Sanjay Rai: Latest News

All news where Sanjay Rai is mentioned

02.08.2022 / 11:53

Covid-19: Bharat Biotech expects DCGI’s nod for nasal vaccine this month

intranasal Covid-19 vaccine in August this year, informed Chairman and Managing Director of BBIL, Krishna Ella as quoted by news agency PTI. He said that the vaccine manufacturing plant of BBIL (Bharat Biotech International Limited) in Gujarat's Ankleshwar is one of the two plants in the world that can manufacture monkeypox vaccine. BBIL's another plant is in Bavarian Nordic, Germany.

Sanjay Rai Krishna Ella India Germany city Delhi vaccine Immunic Provident

Is Covid in endemic phase? Expert explains what surge, fall in cases suggest

NEW DELHI : The coronavirus pandemic is transitioning into its endemic phase and at such point, rise and fall of cases is a common phenomenon, experts said on Friday. This comes at a time when India has witnessed a 30% jump in Covid-19 cases as the country reported 17,336 cases in a day. According to the latest data by the union ministry of health, the death toll climbed to 5,24,954 with 13 new fatalities reported today.

Sanjay Rai city New Delhi India city Delhi covid-19 pandemic infection

Is recent COVID surge an alarm for the 4th wave? Check symptoms to watch out for

Omicron which had already peaked earlier this year. So catching a severe infection from its subvariant for the second time is highly unlikely.

Sanjay Rai India city Delhi virus symptoms Waves

Mumbai sees 50% jump in Covid cases in just 5 days: Is it the new epicentre of 4th wave?

fourth wave mostly because the variant that is circulating currently is Omicron which had already peaked in January with the city recording 20,000 cases every day. So catching a severe infection for the second time is highly unlikely.Trend graph of Mumbai shows a silent wave ,mild omicron variants. Protect Vulnerables ,Keep close watch on hospitalization, Covid-19 appropriate recommended esp in indoor closed environments Avoid crowding.Make Masking a health habit .Stay Vigilant without panic .

Sanjay Rai India city Mumbai city However city Delhi covid-19 Waves Citi

‘Viruses like corona do not end quickly’: AIIMS doctor on future of pandemic in India

Covid-19. These types of viruses do not end quickly and fluctuations will keep happening. We should move toward normalcy," said Dr Sanjay Rai, senior epidemiologist at AIIMS.

Rajesh Bhushan Sanjay Rai India covid-19 infection Waves

Community medicine expert opposes mixing of doses of covid vaccines

NEW DELHI :

Sanjay Rai city New Delhi India county Christian covid-19 vaccine Government

AIIMS receives at least 100 volunteers for intranasal Covid vaccine trial

NEW DELHI :

Sanjay Rai city New Delhi India city Delhi city Hyderabad covid-19 vaccine Volunteers

Is 4th Covid wave coming? Will it have serious impact on India? Top health experts answer

The lowest daily rise in two years:-

Will Covid Sanjay Rai India covid-19 infection Waves

Covid-19 update: India's single-day rise in Covid-19 cases drop, 3,116 cases logged in 24 hours

Covid-19 cases, India on Sunday reported 3,116 fresh Covid-19 cases in the last 24 hour period, according to updated data shared by the Union Health Ministry. The active caseload in the country stands at 38,069 on Sunday, the data further revealed.

Sanjay Rai city New Delhi India city Hyderabad covid-19 vaccine reports

Will the nasal vaccine be effective in preventing Covid-19 infection? AIIMS doctor explains

ANI, if the nasal vaccine is going to provide mucosal immunity, it would be a great achievement for human race. “No vaccine is completely effective in preventing infection. We are hoping this vaccine to provide mucosal immunity to prevent further infection," he said.

Bharat Biotech Sanjay Rai India city Delhi city Hyderabad covid-19 vaccine prevention

Covid-19 nasal vaccine could be a game-changer, says AIIMS epidemiologist

NEW DELHI :

Bharat Biotech Sanjay Rai city New Delhi India city Delhi city Hyderabad covid-19 vaccine epidemiologist

New Covid variant may bypass immunity acquired through vaccines, warns AIIMS doctor

Covid-19 variant B.1.1.529 may be able to bypass one's existing immunity acquired through vaccine or natural infection, reported news agency ANI, quoting an AIIMS doctor.

Sanjay Rai India vaccine infection Immunic

Possibility of normalcy by mid-2021 even without Covid-19 vaccine: AIIMS doctor

New Delhi: There is a possibility of situation created by COVID-19 returning to normal by the middle of next year even if a vaccine is not developed by then, Dr Sanjay Rai, Professor in Community Medicine Department at AIIMS here, has said.Dr Rai, who is also a principal investigator of the Bharat Biotech Covaxin clinical trial at AIIMS, said that COVID-19 preventive measures like wearing masks, hand hygiene should be followed till there is an effective vaccine."By mid-next year, there's a possibility of normalcy even if vaccine comes or not. There is always the natural end of any pandemic so it (COVID-19) will end too.

Sanjay Rai city New Delhi covid-19 testing vaccine infection

India's first COVID-19 vaccine Covaxin: From human trials to test results — key updates

Here's all you need to know about the human trial of Covaxin:No side-effect so far: A 30-year-old man took the first dose of COVID-19 vaccine candidate at Delhi's All India Institutes of Medical Sciences (AIIMS) last week as part of human trial. "No immediate side-effects have been observed so far," Dr Sanjay Rai, professor at the centre for community medicine at AIIMS said.Covaxin shows "encouraging" results in PGIMS RohtakThe first phase of human trial was completed in PGIMS Rohtak.

Sanjay Rai India city Delhi hospital covid-19 vaccine Volunteers Updates

Covid-19 vaccine update: AIIMS Delhi to start human trials of Covaxin from today

Covid-19 vaccine candidate Covaxin. The hospital will start enrolling healthy individuals from today onwards, news Agency PTI had reported."Few volunteers have already registered for the trial.

Sanjay Rai India city Delhi hospital covid-19 vaccine Volunteers

Covid-19 update: AIIMS to start clinical trial of indigenous vaccine Covaxin from Monday

NEW DELHI : The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin.Dr Sanjay Rai, Professor at the Centre for Community Medicine at AIIMS told ANI that the hospital will start enrolling healthy individuals from Monday onwards."Today, we got approval from AIIMS Ethics Committee for starting the human clinical trial of the indigenously developed Covaxin. We are launching the enrollment process from Monday.

Sanjay Rai city New Delhi India covid-19 vaccine Volunteers medicines

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0